Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose proton pump inhibitor in triple therapy for Helicobacter pylori eradication
TCTR20210829002Phase 1Completed
- Sponsor
- National Research Council of Thailand
- Start
- Apr 2021
- Countries
- 1
01
Overview
Phase 1, randomised trial in Helicobacter pylori infection (2 arms), sponsored by National Research Council of Thailand. Primary endpoint: Helicobacter pylori eradication rate. Started Apr 2021; status: completed.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20210829002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210829002.